Thomas Malley insider trades
Open-market stock purchases and sales by Thomas Malley, Unknown at Kura Oncology, Inc, from SEC Form 4 filings since Nov 18, 2011.
Track record: 17% of 6 scored buys are up 5% or more since purchase, averaging -34%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | KURA Kura Oncology, Inc | Bought (not open market) | — |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Mar 18, 2026 | KURA Kura Oncology, Inc | Bought (not open market) | — |
Companies traded
- KURA Kura Oncology, Inc: 2 buys, last Jun 4, 2026
- KNSA Kiniksa Pharmaceuticals International, plc: 3 sales, last May 29, 2026
- BGNE BeiGene, Ltd: 1 buy, last Jun 15, 2023
- OVAS OvaScience, Inc: 2 buys, last Jun 13, 2017
- KURO Kura Oncology, Inc: other filings, last Oct 13, 2015
- GEVA Synageva Biopharma Corp: other filings, last Jun 22, 2015
- PBYI Puma Biotechnology, Inc: 4 buys, last Dec 15, 2014
- OVSC OvaScience, Inc: 1 buy, last Mar 18, 2013
- NONE Puma Biotechnology, Inc: other filings, last Feb 13, 2012